Fibroscan Clinics in Ontario
Fibroscans can help determine level of fibrosis in patient’s liver To find the clinic location in Ontario nearest to you, click here. […]
CLHIA report
Canadian Life and Health Insurance Association has produced a very interesting report on prescription drug policy that can be seen here. […]
Walk for Arthritis 2013
On Saturday May 25, the Walk to Fight Arthritis was held as a part of the ORA Annual Meeting.We raised more than $16,000 and had more than 100 participants. Way to go, ORA!! […]
How to bill the Yearly Rheumatoid Arthritis Rheumatology billing code K481
Click on this link to find out how to correctly bill the RA billing code K481 for those RA patients you see 3 times a year or more. You need to record disease […]
2013 ORA Annual Meeting Update
The ORA’s 2013 Annual Meeting was held May 24-26th at the JW Marriott The Rosseau Muskoka Resort in Minett, Ontario. ORA Members can now access the presentations from the scientific sessions by clicking […]
OMA Continuing Medical Education program now with MOHLTC
The OMA CME reimbursement program has been transferred to the MOHLTC but will still provide financial compensation to qualifying physicians (based on practice postal codes). To get further info click here and to […]
Update on Models of Care, EMR and Ontario Biologics Research Initiative
The ORA has been very busy in its various committees. Check here for important updates on Models of Care, EMR and OBRI. […]
OMA agreement: How will it affect you?
ORA Newsletter Winter 2013 OMA Update Our new contract runs until March 2014. It is an improvement on the government’s threatened unilateral changes. The main changes impacting on rheumatology are: 1. An across […]
ORA and third party payers
Ontario Rheumatology Association and Private Payers: An update As many of you know, major changes to the reimbursement of biologics via third party payers have been occurring, with many insurance companies providing group […]
CRA update to Health Canada’s advisory on concomitant methotrexate and PPIs
The Canadian Rheumatology Association has released an update concerning the recent advisory from Health Canada on the concomitant use of Methotrexate and PPIs. An amended release has been made suggesting that the alert […]
